Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. / Nielsen, Sofie Taageby; Lytsen, Rikke Mohr; Strandkjær, Nina; Rasmussen, Ida Juul; Sillesen, Anne Sophie; B. Vøgg, R. Ottilia; Raja, Anna Axelsson; Nordestgaard, Børge G.; Kamstrup, Pia R.; Iversen, Kasper; Bundgaard, Henning; Tybjærg-Hansen, Anne; Frikke-Schmidt, Ruth.

I: European Heart Journal, Bind 44, Nr. 42, 2023, s. 4408-4418.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nielsen, ST, Lytsen, RM, Strandkjær, N, Rasmussen, IJ, Sillesen, AS, B. Vøgg, RO, Raja, AA, Nordestgaard, BG, Kamstrup, PR, Iversen, K, Bundgaard, H, Tybjærg-Hansen, A & Frikke-Schmidt, R 2023, 'Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life', European Heart Journal, bind 44, nr. 42, s. 4408-4418. https://doi.org/10.1093/eurheartj/ehad547

APA

Nielsen, S. T., Lytsen, R. M., Strandkjær, N., Rasmussen, I. J., Sillesen, A. S., B. Vøgg, R. O., Raja, A. A., Nordestgaard, B. G., Kamstrup, P. R., Iversen, K., Bundgaard, H., Tybjærg-Hansen, A., & Frikke-Schmidt, R. (2023). Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. European Heart Journal, 44(42), 4408-4418. https://doi.org/10.1093/eurheartj/ehad547

Vancouver

Nielsen ST, Lytsen RM, Strandkjær N, Rasmussen IJ, Sillesen AS, B. Vøgg RO o.a. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. European Heart Journal. 2023;44(42):4408-4418. https://doi.org/10.1093/eurheartj/ehad547

Author

Nielsen, Sofie Taageby ; Lytsen, Rikke Mohr ; Strandkjær, Nina ; Rasmussen, Ida Juul ; Sillesen, Anne Sophie ; B. Vøgg, R. Ottilia ; Raja, Anna Axelsson ; Nordestgaard, Børge G. ; Kamstrup, Pia R. ; Iversen, Kasper ; Bundgaard, Henning ; Tybjærg-Hansen, Anne ; Frikke-Schmidt, Ruth. / Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. I: European Heart Journal. 2023 ; Bind 44, Nr. 42. s. 4408-4418.

Bibtex

@article{2435f5c38a3a4f61b8600f47199ee244,
title = "Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life",
abstract = "Background and The aims of this study were to investigate lipid parameters during the first 14–16 months of life, to identify influential factors, Aims and to test whether high concentrations at birth predict high concentrations at 2- and 14–16 months. Methods The Copenhagen Baby Heart Study, including 13,354 umbilical cord blood samples and parallel venous blood samples from children and parents at birth (n = 444), 2 months (n = 364), and 14–16 months (n = 168), was used. Results Concentrations of lipids, lipoproteins, and apolipoproteins in umbilical cord blood samples correlated highly with venous blood samples from newborns. Concentrations of low-density lipoprotein (LDL) cholesterol, non-high-density lipoprotein (HDL) cholesterol, apolipoprotein B, and lipoprotein(a) increased stepwise from birth to 2 months to 14–16 months. Linear mixed models showed that concentrations of LDL cholesterol, non-HDL cholesterol, and lipoprotein(a) above the 80th percentile at birth were associated with significantly higher concentrations at 2 and 14–16 months. Finally, lipid concentrations differed according to sex, gestational age, birth weight, breastfeeding, and parental lipid concentrations. Conclusions Lipid parameters changed during the first 14–16 months of life, and sex, gestational age, birth weight, breastfeeding, and high parental concentrations influenced concentrations. Children with high concentrations of atherogenic lipid traits at birth had higher concentrations at 2 and 14–16 months. These findings increase our knowledge of how lipid traits develop over the first 14–16 months of life and may help in deciding the optimal child age for universal familial hypercholesterolaemia screening.",
keywords = "Apolipoproteins, Lipids, Lipoproteins, Prevention, Umbilical cord blood",
author = "Nielsen, {Sofie Taageby} and Lytsen, {Rikke Mohr} and Nina Strandkj{\ae}r and Rasmussen, {Ida Juul} and Sillesen, {Anne Sophie} and {B. V{\o}gg}, {R. Ottilia} and Raja, {Anna Axelsson} and Nordestgaard, {B{\o}rge G.} and Kamstrup, {Pia R.} and Kasper Iversen and Henning Bundgaard and Anne Tybj{\ae}rg-Hansen and Ruth Frikke-Schmidt",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.",
year = "2023",
doi = "10.1093/eurheartj/ehad547",
language = "English",
volume = "44",
pages = "4408--4418",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "42",

}

RIS

TY - JOUR

T1 - Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life

AU - Nielsen, Sofie Taageby

AU - Lytsen, Rikke Mohr

AU - Strandkjær, Nina

AU - Rasmussen, Ida Juul

AU - Sillesen, Anne Sophie

AU - B. Vøgg, R. Ottilia

AU - Raja, Anna Axelsson

AU - Nordestgaard, Børge G.

AU - Kamstrup, Pia R.

AU - Iversen, Kasper

AU - Bundgaard, Henning

AU - Tybjærg-Hansen, Anne

AU - Frikke-Schmidt, Ruth

N1 - Publisher Copyright: © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2023

Y1 - 2023

N2 - Background and The aims of this study were to investigate lipid parameters during the first 14–16 months of life, to identify influential factors, Aims and to test whether high concentrations at birth predict high concentrations at 2- and 14–16 months. Methods The Copenhagen Baby Heart Study, including 13,354 umbilical cord blood samples and parallel venous blood samples from children and parents at birth (n = 444), 2 months (n = 364), and 14–16 months (n = 168), was used. Results Concentrations of lipids, lipoproteins, and apolipoproteins in umbilical cord blood samples correlated highly with venous blood samples from newborns. Concentrations of low-density lipoprotein (LDL) cholesterol, non-high-density lipoprotein (HDL) cholesterol, apolipoprotein B, and lipoprotein(a) increased stepwise from birth to 2 months to 14–16 months. Linear mixed models showed that concentrations of LDL cholesterol, non-HDL cholesterol, and lipoprotein(a) above the 80th percentile at birth were associated with significantly higher concentrations at 2 and 14–16 months. Finally, lipid concentrations differed according to sex, gestational age, birth weight, breastfeeding, and parental lipid concentrations. Conclusions Lipid parameters changed during the first 14–16 months of life, and sex, gestational age, birth weight, breastfeeding, and high parental concentrations influenced concentrations. Children with high concentrations of atherogenic lipid traits at birth had higher concentrations at 2 and 14–16 months. These findings increase our knowledge of how lipid traits develop over the first 14–16 months of life and may help in deciding the optimal child age for universal familial hypercholesterolaemia screening.

AB - Background and The aims of this study were to investigate lipid parameters during the first 14–16 months of life, to identify influential factors, Aims and to test whether high concentrations at birth predict high concentrations at 2- and 14–16 months. Methods The Copenhagen Baby Heart Study, including 13,354 umbilical cord blood samples and parallel venous blood samples from children and parents at birth (n = 444), 2 months (n = 364), and 14–16 months (n = 168), was used. Results Concentrations of lipids, lipoproteins, and apolipoproteins in umbilical cord blood samples correlated highly with venous blood samples from newborns. Concentrations of low-density lipoprotein (LDL) cholesterol, non-high-density lipoprotein (HDL) cholesterol, apolipoprotein B, and lipoprotein(a) increased stepwise from birth to 2 months to 14–16 months. Linear mixed models showed that concentrations of LDL cholesterol, non-HDL cholesterol, and lipoprotein(a) above the 80th percentile at birth were associated with significantly higher concentrations at 2 and 14–16 months. Finally, lipid concentrations differed according to sex, gestational age, birth weight, breastfeeding, and parental lipid concentrations. Conclusions Lipid parameters changed during the first 14–16 months of life, and sex, gestational age, birth weight, breastfeeding, and high parental concentrations influenced concentrations. Children with high concentrations of atherogenic lipid traits at birth had higher concentrations at 2 and 14–16 months. These findings increase our knowledge of how lipid traits develop over the first 14–16 months of life and may help in deciding the optimal child age for universal familial hypercholesterolaemia screening.

KW - Apolipoproteins

KW - Lipids

KW - Lipoproteins

KW - Prevention

KW - Umbilical cord blood

U2 - 10.1093/eurheartj/ehad547

DO - 10.1093/eurheartj/ehad547

M3 - Journal article

C2 - 37632410

AN - SCOPUS:85178288812

VL - 44

SP - 4408

EP - 4418

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 42

ER -

ID: 376413205